MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss | Personnel Moves, July 28, 2016

Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss | Personnel Moves, July 28, 2016

By

Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss

zeiss-mazzo

Carl Zeiss Meditec (ETR:AFX) said this week it tapped ex-AcuFocus CEO James Mazzo as the global president of its ophthalmology business as well as managing the entire company’s U.S. sales and service center.

Mazzo comes from a 3-year run as president and CEO at AcuFocus, where he led the the company to FDA approval for its Kamra inlay. AcuFocus tapped Alan Waterhouse to operate as Prez & COO and Dr. William Link as board chair as Mazzo steps away.

“I am privileged and honored to be joining Carl Zeiss Meditec. The company has been an innovative leader in the industry for over 100 years. The broad line of technology and commitment to our industry is exciting. I look forward to continuing this excellence and building Zeiss into the premier ophthalmic franchise,” James Mazzo said in prepared remarks.

In March Mazzo, the former Advanced Medical Optics CEO who was indicted 2 years ago, sought a stay pending a U.S. Supreme Court decision over issues he claims could affect the insider trading charges alleged in his case.

Mazzo was indicted in September 2014, stemming from Abbott‘s (NYSE:ABT) $2.8 billion acquisition of AMO in 2009. Prosecutors accused Mazzo of tipping close friend and neighbor Doug DeCinces about the deal. DeCinces, a former baseball player for the Baltimore Orioles, allegedly passed the information on to former teammate Eddie Murray, who agreed to settle his case for $358,000 but admitted no wrongdoing. (DeCinces agreed in 2011 to pony up $2.5 million (but admitted no guilt) to settle similar charges leveled by the SEC.)

Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • 3D ‘lung-on-a-chip’ will test COVID-19 drugs
    Researchers in Boston have developed a novel technology to study the effects of COVID-19 and on lung tissue, and to test treatments for it. The “3-D lung-on-a-chip” by Brigham & Women’s Hospital researchers models the distal lung and alveolar structures — the tiny air sacs that take in oxygen as you breathe. They are studying… […]
  • FDA maps return to inspection normalcy
    The FDA has mapped out how it plans to catch up on pandemic-delayed facility inspections — including 2,426 medtech inspections. In a new report called Resiliency Roadmap for FDA Inspectional Oversight, the agency said it will prioritize inspections in terms of urgency and the threat posed by COVID-19 domestically and abroad. The FDA had planned… […]
  • Zimmer Biomet is looking to put sensors in more than just knee implants
    Even as Zimmer Biomet prepares to launch its Persona-IQ smart knee implant later this year, the ortho device giant is looking at additional opportunities to package sensors inside ortho implants. Startup Canary Medical (Vancouver, British Columbia), which created the Canary Health Implantable Reporting Processor (CHIRP) that is going inside the Persona-IQ, has cemented a long-term… […]
  • Protolabs meets on earnings, beats on revenue in Q1
    Protolabs (NYSE: PRLB) today met the Wall Street consensus on its Q1 earnings, surpassing analysts’ expectations when it came to revenue. The Maple Plain, Minn.–based digital manufacturer — which supports medtech and many other industries — reported profits of $3.7 million, or 13¢ per share — about a quarter of the profits that Protolabs saw… […]
  • Allied Motion releases motion control design guide for surgical robots
    Allied Motion Technologies (Amherst, N.Y.) has released a new guide to its custom motion control products for advanced medical robot applications. The guide highlights several motors, drives and control systems, and the uses of each for specific applications. Allied offers co-design and development, has ISO 13485-certified production facilities and a global supply chain . Specific… […]
  • Quasar Medical names new CEO
    Contract manufacturer Quasar Medical announced today that its board of directors has named Alex Wallstein as CEO. Ayal Amitai, CEO since July 2005, is stepping down and transitioning to executive director of the board and senior advisor to the CEO, as well as retaining his shareholdings in Quasar. Wallstein comes with many years of senior… […]
  • Wytech Industries names new president
    Specialty and precision wire manufacturer Wytech Industries (Rahway, N.J.) today announced it has named David Ohmann as president. Ohmann has nearly 25 years of experience in international, orthopedic and advanced surgical medical device segments. Prior to joining Wytech, Ohmann held sales and marketing leadership positions at Heraeus and MicroGroup (a TE Connectivity company). Ohmann has a… […]
  • Spectrum Plastics acquires Laser Light Technologies
    Spectrum Plastics Group has announced the acquisition of substantially all assets of Laser Light Technologies. An ISO 9001- and ISO 13485-certified organization based in Hermann, Mo., Laser Light Technologies provides custom laser processing systems and services using excimer, femtosecond, picosecond and YAG laser technologies. “The addition of the talented team at Laser Light Technologies brings… […]
  • Dymax announces deal with coatings company
    Dymax and nanocoatings manufacturer HZO today announced a strategic partnership. The deal will add 3,000 coatings formulations to HZO’s portfolio, facilitate joint product development, and use Dymax’s global sales channel to extend market reach. Dymax (Torrington, Conn.) manufactures rapid light-cure adhesives, conformal coatings, potting compounds and complementary dispensing and curing equipment used in medtech and… […]
  • Qosina releases 2022 catalog
    Qosina said today it has released the latest edition of its product catalog in both print and digital formats. The 2022 product catalog includes thousands of single-use medical and pharma components depicted in full-scale photos on a one-centimeter grid to help design engineers visualize their next-generation medical device, according to the Ronkonkoma, N,.Y.-based company. Qosina… […]
  • Medline completes $1.5B spending plan
    Medline Industries announced this week that it has completed a three-year, $1.5 billion capital spending campaign. The Northfield, Ill.-based company, which is reportedly up for sale, said it invested the money in new distribution centers, manufacturing capabilities and IT upgrades to improve customers’ e-commerce experience. All told, the initiative added approximately 8,500 new jobs, eight… […]